Detalles de la búsqueda
1.
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.
Lancet Oncol
; 14(8): 777-86, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23782814
2.
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer.
Lung Cancer
; 98: 1-8, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27393499
3.
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.
Clin Cancer Res
; 21(14): 3196-203, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25829397
4.
Chromosomal aberrations among Filipino health workers at the chemotherapy oncology wards/clinics of a tertiary government hospital
Acta Medica Philippina
; : 11-16, 2014.
Artículo
en Inglés
| WPRIM | ID: wpr-633712
Resultados
1 -
4
de 4
1
Próxima >
>>